Bimatoprost in the Treatment of Eyelash Hypotrichosis

Phase 3 Completed 464 enrolled Allergan

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the safety and efficacy of bimatoprost solution formulation A compared with bimatoprost solution 0.03% (LATISSE®) and vehicle in the treatment of eyelash hypotrichosis (inadequate eyelashes).

Timeline

Start: 2012-11
Primary completion: 2014-02
Completion: 2014-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bimatoprost	Other / unclassified	0.03 %	Topical

Bimatoprost in the Treatment of Eyelash Hypotrichosis

Summary

Timeline

Drugs

Indications